Aurentz Vincent bought IKT
June 26, 2026 · Form 4 insider transaction
Aurentz Vincent bought 155,000 shares of Inhibikase Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
155,000
Price
$0.00
Total value
N/A
InsiderAurentz Vincent
RoleDirector
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJune 26, 2026
Filing dateJune 30, 2026
Shares owned after155,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The options will vest on the earlier of June 26, 2027 or the day prior to the next annual meeting of stockholders, subject to the director's continued service through such date.